Ana
López Martín
Argitalpenak (22) Ana López Martín argitalpenak
2024
-
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
British Journal of Cancer, Vol. 130, Núm. 3, pp. 417-424
2023
-
Effects of Physical Activity Interventions on Self-Perceived Health Status among Lung Cancer Patients: Systematic Review and Meta-Analysis
Cancers, Vol. 15, Núm. 23
-
Immunogenicity of COVID-19 vaccines in lung cancer patients
Lung Cancer, Vol. 184
-
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib
Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e166-e174
2022
-
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
Translational Lung Cancer Research, Vol. 11, Núm. 1, pp. 53-63
2021
-
Article a multicenter analysis of the outcome of cancer patients with neutropenia and covid-19 optionally treated with granulocyte-colony stimulating factor (G-csf): A comparative analysis
Cancers, Vol. 13, Núm. 16
-
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial
Molecular Oncology, Vol. 15, Núm. 1, pp. 43-56
-
Lung cancer patients with COVID-19 in Spain: GRAVID study
Lung Cancer, Vol. 157, pp. 109-115
2017
-
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial
Journal of Thoracic Oncology, Vol. 12, Núm. 4, pp. 752-762
2016
-
Multidisciplinary approach of unresectable head and neck cancer
Head and Neck Cancer: Multimodality Management, Second Edition (Springer International Publishing), pp. 617-624
-
Targeted therapy in locally advanced and recurrent/metastatic head and neck squamous cell carcinoma (LA-R/M HNSCC)
Cancers, Vol. 8, Núm. 3
2015
-
Los profesionales de la accesibilidad
Madrid Accessibility Week: Compartiendo Accesibilidad : Edición 2014 (Universidad Internacional de Andalucía), pp. 63-66
2013
-
Phase i study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology, Vol. 72, Núm. 1, pp. 75-83
2012
-
Toxicidad pulmonar grave relacionada con la administración de gemcitabina
Farmacia Hospitalaria
2007
-
Prognostic value of KIT expression in small cell lung cancer
Lung Cancer, Vol. 56, Núm. 3, pp. 405-413
2005
-
Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 24, Núm. 4, pp. 291-293
2004
-
Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia
Cancer, Vol. 100, Núm. 11, pp. 2462-2469
-
Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors
British Journal of Cancer, Vol. 91, Núm. 12, pp. 2005-2011
2003
-
Hypervascular pelvic mass: An infrequent cause of digestive hemorrhage [4]
Revista Clinica Espanola
-
Tumores del tracto genitourinario
Oncología en atención primaria (Madrid: Nova sidonia oncología y hematología), pp. 341-354